Clinical trial completion rates decline during COVID-19 pandemic
A study by Penn State College of Medicine researchers found that clinical trial completion rates declined during the COVID-19 pandemic.
Image: Getty Images | AnnaStills
Clinical trial completion rates decline during COVID-19 pandemic
Zachary Sweger
April 07, 2021
HERSHEY, Pa. Social distancing and lockdowns may have reduced the spread of COVID-19, but researchers from Penn State College of Medicine also report those actions may have affected clinical researchers’ ability to finish trials. Study completion rates dropped worldwide between 13% and 23%, depending on the type of research sponsor and geographic location, between April and October 2020.
Researchers previously reported that more than 80% of clinical trials suspended between March 1 and April 26, 2020, noted the pandemic as their chief reason for halting activity. Patient enrollment in studies was lower in April 2020, compared to April 2019. Arthu
Pandemic has put many clinical trials on hold
By (0)
Technicians work in the ISO-certified cleanroom laboratory at Cincinnati Children s, where gene-correction therapies are tested and produced for clinical trials. File Photo by Cincinnati Children s
Fewer clinical trials are being completed during the pandemic, which experts say could affect medical research for decades to come.
Previously, it was reported that more than 80% of clinical trials were suspended between March 1 and April 26, 2020, with the pandemic cited as the main reason.
Advertisement
In this study, researchers at Penn State College of Medicine examined more than 117,000 trials in the United States, Europe, Asia and other regions to find out how the pandemic has affected clinical research.
Pandemic s mitigation efforts may have contributed to drop in clinical trial completion rates
Social distancing and lockdowns may have reduced the spread of COVID-19, but researchers from Penn State College of Medicine also report those actions may have affected clinical researchers ability to finish trials. Study completion rates dropped worldwide between 13% and 23%, depending on the type of research sponsor and geographic location, between April and October 2020.
Researchers previously reported that more than 80% of clinical trials suspended between March 1 and April 26, 2020, noted the pandemic as their chief reason for halting activity. Patient enrollment in studies was lower in April 2020, compared to April 2019. Arthur Berg, associate professor of public health sciences, and Nour Hawila, a biostatistics doctoral candidate, investigated how these trends may have affected the completion of clinical trials.
Clinical trial completion rates decline during COVID-19 pandemic miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.